News InflaRx Announces Positive Topline Results from the Single Ascending Dose (SAD) Phase I Study with C5aR Inhibitor INF904 Staff September 11, 2023 Post Views: 29 Related Continue Reading Previous Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology TherapeuticsNext Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors More Stories Healthcare News NuGen Medical Completes Delivery and First Sale of 500 InsuJet(TM) Devices and Consumables in Romania Staff September 20, 2023 News Izotropic Closes Non-Brokered Private Placement Staff September 20, 2023 News Yada Yoga Extends Wellness Support to Protestors in the Entertainment Industry on the Picket Lines Staff September 20, 2023
